Correlation Between ChemoMetec and TROPHY GAMES
Can any of the company-specific risk be diversified away by investing in both ChemoMetec and TROPHY GAMES at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ChemoMetec and TROPHY GAMES into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ChemoMetec AS and TROPHY GAMES Development, you can compare the effects of market volatilities on ChemoMetec and TROPHY GAMES and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ChemoMetec with a short position of TROPHY GAMES. Check out your portfolio center. Please also check ongoing floating volatility patterns of ChemoMetec and TROPHY GAMES.
Diversification Opportunities for ChemoMetec and TROPHY GAMES
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between ChemoMetec and TROPHY is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding ChemoMetec AS and TROPHY GAMES Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TROPHY GAMES Development and ChemoMetec is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ChemoMetec AS are associated (or correlated) with TROPHY GAMES. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TROPHY GAMES Development has no effect on the direction of ChemoMetec i.e., ChemoMetec and TROPHY GAMES go up and down completely randomly.
Pair Corralation between ChemoMetec and TROPHY GAMES
Assuming the 90 days trading horizon ChemoMetec AS is expected to generate 2.13 times more return on investment than TROPHY GAMES. However, ChemoMetec is 2.13 times more volatile than TROPHY GAMES Development. It trades about 0.15 of its potential returns per unit of risk. TROPHY GAMES Development is currently generating about -0.22 per unit of risk. If you would invest 38,800 in ChemoMetec AS on October 6, 2024 and sell it today you would earn a total of 11,350 from holding ChemoMetec AS or generate 29.25% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
ChemoMetec AS vs. TROPHY GAMES Development
Performance |
Timeline |
ChemoMetec AS |
TROPHY GAMES Development |
ChemoMetec and TROPHY GAMES Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ChemoMetec and TROPHY GAMES
The main advantage of trading using opposite ChemoMetec and TROPHY GAMES positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ChemoMetec position performs unexpectedly, TROPHY GAMES can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TROPHY GAMES will offset losses from the drop in TROPHY GAMES's long position.ChemoMetec vs. cBrain AS | ChemoMetec vs. Ambu AS | ChemoMetec vs. Genmab AS | ChemoMetec vs. Zealand Pharma AS |
TROPHY GAMES vs. North Media AS | TROPHY GAMES vs. Bactiquant AS | TROPHY GAMES vs. FOM Technologies AS | TROPHY GAMES vs. MapsPeople AS |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |